As of 2025-11-28, the Relative Valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 1.30 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.71 CAD, the upside of Medexus Pharmaceuticals Inc based on Relative Valuation is -52.0%.
The range of the Relative Valuation is 0.34 - 2.52 CAD.
| Range | Selected | |
| Trailing P/E multiples | 28.7x - 36.4x | 32.6x |
| Forward P/E multiples | 22.7x - 29.8x | 26.2x |
| Fair Price | 0.34 - 2.52 | 1.30 |
| Upside | -87.5% - -7.2% | -52.0% |
| Date | P/E |
| 2025-11-26 | 229.46 |
| 2025-11-25 | 228.61 |
| 2025-11-24 | 229.46 |
| 2025-11-21 | 228.61 |
| 2025-11-20 | 220.99 |
| 2025-11-19 | 224.38 |
| 2025-11-18 | 228.61 |
| 2025-11-17 | 228.61 |
| 2025-11-14 | 228.61 |
| 2025-11-13 | 227.77 |
| 2025-11-12 | 228.61 |
| 2025-11-11 | 226.92 |
| 2025-11-10 | 227.77 |
| 2025-11-07 | 226.92 |
| 2025-11-06 | 224.38 |
| 2025-11-05 | 226.92 |
| 2025-11-04 | 227.77 |
| 2025-11-03 | 237.08 |
| 2025-10-31 | 237.08 |
| 2025-10-30 | 238.77 |
| 2025-10-29 | 243.86 |
| 2025-10-28 | 237.93 |
| 2025-10-27 | 244.70 |
| 2025-10-24 | 243.01 |
| 2025-10-23 | 241.31 |
| 2025-10-22 | 231.15 |
| 2025-10-21 | 232.85 |
| 2025-10-20 | 243.86 |
| 2025-10-17 | 228.61 |
| 2025-10-16 | 234.54 |
| 2025-10-15 | 236.23 |
| 2025-10-14 | 236.23 |
| 2025-10-10 | 229.46 |
| 2025-10-09 | 241.31 |
| 2025-10-08 | 247.24 |
| 2025-10-07 | 240.47 |
| 2025-10-06 | 237.08 |
| 2025-10-03 | 242.16 |
| 2025-10-02 | 245.55 |
| 2025-10-01 | 216.76 |
| 2025-09-30 | 220.15 |
| 2025-09-29 | 227.77 |
| 2025-09-26 | 234.54 |
| 2025-09-25 | 251.48 |
| 2025-09-24 | 253.17 |
| 2025-09-23 | 248.94 |
| 2025-09-22 | 253.17 |
| 2025-09-19 | 256.56 |
| 2025-09-18 | 248.09 |
| 2025-09-17 | 250.63 |